Isha Sharma is the Director of Trayambak Overseas Private Limited based at Noida. She is a registered patent agent whose experience includes 7 years with her clients across the globe. She has done her BTech and MTech in biotechnology at Amity University, India. She has also done 1 year PG diploma in IPR and is also qualiï¬ ed to prac se law in India. She prac ces as a registered patent agent. Isha also train students and corporates about the importance of IPR. She has conducted Intellectual Property Awareness workshop & lectures at IIT, Amity University, Geeta Law College, Panipat, IIPTA, Delhi and NITIE, Mumbai. She has also been invited as a speaker at business entrepreneur’s summit, 2018 Delhi & Speaker at Women entrepreneur’s summit, 2018, Jalandhar, India.
Abstract
The ra onale of the intellectual property (IP) system in general, and the patent system, is to make investment in innova on a rac ve and to off er a mechanism which ensures that the knowledge contained in patent applica ons is accessible to society. In this way, it seeks to balance compe ng private and public interests. The cost and me required to develop new medicine or devices can run into the billions of dollars and take over a decade. To protect their enormous sunk costs, pharmaceu cal and biotech companies must be conï¬ dent that compe tors will not be able to launch copycat or generic versions of those medicines or devices before they have been able to recoup their costs and make a proï¬ t. Intellectual property rights – limited terms of patent protec on during which companies can market their products without compe on – have been ins tuted to encourage investment in R&D. Innova on and
the intellectual property (IP) o en underpinning it are crucial drivers of human progress. Innova on saves lives, facilitates human connec ons that have even sparked revolu ons and entertains and enchants people around the globe. IP rights and enforcement of those rights globally is vital to the con nued fl ow of future new inven ons as free markets depend on IP and the resul ng innova on. Innova on, helps to ï¬ nd treatment paths, improved or new medica on, be er equipment’s & devices and more to help pa ents lead longer and be er lives. Intellectual Property has enabled the research and development of today’s medicines and it will lead to the development cure and treatment of currently s ll unmet needs. Intellectual Property is at the heart of our health system as it sustains the ï¬ nancing model for research and development.
Current Trends in Cardiology
Cardiac Surgery
Cardio-Oncology
Cardiac Engineering, Biomimetic and Implants
Cardiac Nutrition and Public Health
Cardiology Genetics
Brain-Heart disorders and Neurocardiology
Pediatric & Fetal Cardiology
Clinical Cardiology: Pharmacology and Toxicology
Diagnostics, Cardiac Imaging and Nuclear Cardiology